CO6771460A2 - Treatment of vaginal atrophy with new indication for myrrh - Google Patents
Treatment of vaginal atrophy with new indication for myrrhInfo
- Publication number
- CO6771460A2 CO6771460A2 CO13231573A CO13231573A CO6771460A2 CO 6771460 A2 CO6771460 A2 CO 6771460A2 CO 13231573 A CO13231573 A CO 13231573A CO 13231573 A CO13231573 A CO 13231573A CO 6771460 A2 CO6771460 A2 CO 6771460A2
- Authority
- CO
- Colombia
- Prior art keywords
- treatment
- myrrh
- vaginal atrophy
- new indication
- atrophy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
La invención consiste en una nueva indicación para a mirra, concretamente el tratamiento de la atrofia vaginal como síntoma menopáusico. Además, la invención incluye un preparado farmacéutico en forma de dosis vaginal para el tratamiento de dicha atrofia, así como un procedimiento para elaborar un preparado farmacéutico contra la atrofia vaginal como síndrome de la menopausia.The invention consists of a new indication for myrrh, specifically the treatment of vaginal atrophy as a menopausal symptom. In addition, the invention includes a pharmaceutical preparation in the form of a vaginal dose for the treatment of said atrophy, as well as a method for preparing a pharmaceutical preparation against vaginal atrophy as a menopause syndrome.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/050,225 US8287924B2 (en) | 2011-03-17 | 2011-03-17 | Treatment of menopausal symptoms as novel indication for myrrh |
EP11158593.1A EP2500026B1 (en) | 2011-03-17 | 2011-03-17 | Treatment of menopausal symptoms as novel indication for myrrh |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6771460A2 true CO6771460A2 (en) | 2013-10-15 |
Family
ID=45929506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13231573A CO6771460A2 (en) | 2011-03-17 | 2013-09-30 | Treatment of vaginal atrophy with new indication for myrrh |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP5519879B2 (en) |
KR (1) | KR20130130034A (en) |
AU (1) | AU2012228213B2 (en) |
BR (1) | BR112013023092A2 (en) |
CA (1) | CA2829792C (en) |
CO (1) | CO6771460A2 (en) |
MX (1) | MX352788B (en) |
WO (1) | WO2012123539A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2967506A1 (en) | 2016-01-18 | 2017-07-18 | Nadiah Abdulkarim A. Alessa | Composition for treatment and preventative of the human papilloma virus hpv infection, ulcerations and boils |
CN112236198A (en) * | 2018-06-29 | 2021-01-15 | 宝洁公司 | Vaginal care composition |
WO2021123925A1 (en) * | 2019-12-15 | 2021-06-24 | Banooye Armaghan Teb | Herbal compositions and administration methods for the treatment of infections and inflammation of vulvovaginal and the pelvic organs |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4592912A (en) | 1983-10-31 | 1986-06-03 | Harriet Nickolaus | Ache and pain relieving and preventing composition |
US4719111A (en) | 1985-06-14 | 1988-01-12 | Wilson Lynn M | Novel composition for treatment of decubitus ulcers |
JPS63104924A (en) * | 1986-10-20 | 1988-05-10 | Kanebo Ltd | Pessary |
AU630561B2 (en) | 1990-06-12 | 1992-10-29 | Cathy Palou | A therapeutic preparation containing myrrh for treating skin disorders |
US6350784B1 (en) * | 1996-02-12 | 2002-02-26 | Meryl J. Squires | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
US5248503A (en) | 1992-01-03 | 1993-09-28 | Emanuel King Rosalba | Herbal dietary supplement |
US6077513A (en) | 1996-05-02 | 2000-06-20 | Massoud; Ahmed Mohamed Ali | Drug for treatment of bilharziasis (Schistosomiasis) |
ZA200000192B (en) * | 1998-10-30 | 2000-08-07 | Jullienne Jacques Roger Jean M | Novel composition. |
US6893648B2 (en) | 2002-01-04 | 2005-05-17 | Harold Mermelstein | Composition and method for treatment of vaginal dryness |
CN1559586A (en) * | 2004-03-04 | 2005-01-05 | 健 曹 | External used Chinese patent drug for trenting gynecopathy |
CN1679687A (en) | 2005-02-02 | 2005-10-12 | 姚素英 | External-applied capsules for treating gynecopathy and preparation thereof |
CN101057892B (en) * | 2006-04-19 | 2010-11-10 | 河南省宛西制药股份有限公司 | Medicinal composition for treating vaginal diseases and its preparation method and application |
CN101849981B (en) * | 2010-06-22 | 2011-11-23 | 南京中医药大学 | Myrrh target area for treatment of gynecological tumor and preparation method and application thereof |
-
2012
- 2012-03-15 CA CA2829792A patent/CA2829792C/en active Active
- 2012-03-15 BR BR112013023092A patent/BR112013023092A2/en not_active Application Discontinuation
- 2012-03-15 KR KR1020137021591A patent/KR20130130034A/en not_active Application Discontinuation
- 2012-03-15 WO PCT/EP2012/054548 patent/WO2012123539A1/en active Application Filing
- 2012-03-15 JP JP2013555906A patent/JP5519879B2/en not_active Expired - Fee Related
- 2012-03-15 MX MX2013010415A patent/MX352788B/en active IP Right Grant
- 2012-03-15 AU AU2012228213A patent/AU2012228213B2/en not_active Ceased
-
2013
- 2013-09-30 CO CO13231573A patent/CO6771460A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2013010415A (en) | 2013-12-02 |
JP5519879B2 (en) | 2014-06-11 |
AU2012228213B2 (en) | 2015-08-06 |
WO2012123539A1 (en) | 2012-09-20 |
JP2014508158A (en) | 2014-04-03 |
AU2012228213A1 (en) | 2013-09-12 |
CA2829792C (en) | 2017-04-04 |
BR112013023092A2 (en) | 2016-12-06 |
MX352788B (en) | 2017-12-05 |
CA2829792A1 (en) | 2012-09-20 |
KR20130130034A (en) | 2013-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150326A (en) | AUTOTAXIN INHIBITORS | |
CR20140231A (en) | ACETIC BENZOTIAZOL-6-IL ACID DERIVATIVES AND THEIR USE TO TREAT AN HIV INFECTION | |
PE20150631A1 (en) | CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR | |
CU20170009A7 (en) | 2- (MORFOLIN-4-IL) -1,7-USEFUL NAFTIRIDINS IN THE TREATMENT OR PROFILAXIS OF HYPERPROLIFERATIVE DISEASES | |
JP2014515038A5 (en) | ||
CL2014001049A1 (en) | Compounds derived from substituted purine, mtor inhibitors; pharmaceutical composition; pharmaceutical combination; use for the treatment or prevention of cancer, a neurodegenerative disorder or an ophthalmological disease. | |
UY34705A (en) | MULTIPLE LAYER FILMS ABLE TO RELEASE ACTIVE INGREDIENTS FOR A LIMITED TIME PERIOD | |
CL2015001610A1 (en) | Compounds derived from pyrimido- [4,5-b] -quinoline-4,5 (3h, 10h) -diones to be used as a medicament for the treatment of a disease caused by a nonsense mutation; composition and pharmaceutical combination that includes them. | |
DOP2017000146A (en) | PIRAZOLPIRIDINAMINS AS INHIBITORS OF MKNK1 AND MKNK2 | |
EP3034082A4 (en) | Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients | |
PE20142043A1 (en) | SELECTIVE METABOLIC APPROACH TO INCREASE ORAL BIOAVAILABILITY OF PHENYLEPHRIN AND OTHER METABOLIC BIOACTIVES | |
DOP2016000118A (en) | TIENOPIRIMIDINS AS MKNK1 AND MKNK2 INHIBITORS | |
UY34786A (en) | PROCEDURE FOR THE MANUFACTURE OF A PHARMACEUTICAL FORM INCLUDING NIFEDIPINO AND CANDESARTAN CILEXETILO | |
IN2014CH00395A (en) | ||
ES2524385R1 (en) | Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases | |
PH12016502243A1 (en) | Pharmaceutical compositions for treating infectious diseases | |
PE20150721A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING GEMIGLIPTIN AND METFORMIN, AND METHOD FOR THEIR PREPARATION | |
ES2415029R1 (en) | Pharmaceutical composition and method to inhibit the production or amplify the elimination of the P24 protein. | |
CO2017007316A2 (en) | Pharmaceutical formulation | |
CL2015002466A1 (en) | Organic compound formulations | |
CO7121334A2 (en) | Vesicular formulations | |
CO6771460A2 (en) | Treatment of vaginal atrophy with new indication for myrrh | |
BR112013019798A2 (en) | bakuchiol compositions for treating postinflammatory hyperpigmentation. | |
AR098614A1 (en) | COMPOUND FOR THE TREATMENT OF SEVERE HYPOGLYCEMIA | |
UY35033A (en) | FORMULATION IN TABLETS OF A 3-CINASA PHOSPHYTIDYLINOSITOL INHIBITOR |